2020
DOI: 10.1002/hep4.1583
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Kidney Disease in Patients with Chronic Liver Disease: What Is the Price Tag?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…In contrast, in our patient cohort, 56 of the 89 tunneled CVCs (62.9%) inserted in patients in the thromboelastography-guided transfusion group and 52 of the 275 tunneled CVCs (18.9%) inserted in patients in the conventional transfusion group were TDCs, which demonstrates that a considerable proportion of patients had concomitant kidney failure requiring kidney replacement therapy. Acute and chronic kidney disease are commonly encountered in patients with decompensated cirrhosis ( 30 , 31 ) and acute liver failure ( 32 ) and have been associated with further increased risk of bleeding ( 33 ) and thrombosis ( 34 ) in patients with liver disease. For example, a retrospective chart review study ( 33 ) analyzing patients with decompensated cirrhosis undergoing paracentesis (considered a low bleeding risk procedure by the 2019 Society of Interventional Radiology guidelines [ 21 ] similar to central vein cannulation), demonstrated that acute kidney injury before paracentesis was an independent predictor of post-paracentesis bleeding (odds ratio, 4.3; 95% CI, 1.3–13.5; p = 0.01), independent of coagulation parameters (platelets, INR), and severity of liver disease (MELD).…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, in our patient cohort, 56 of the 89 tunneled CVCs (62.9%) inserted in patients in the thromboelastography-guided transfusion group and 52 of the 275 tunneled CVCs (18.9%) inserted in patients in the conventional transfusion group were TDCs, which demonstrates that a considerable proportion of patients had concomitant kidney failure requiring kidney replacement therapy. Acute and chronic kidney disease are commonly encountered in patients with decompensated cirrhosis ( 30 , 31 ) and acute liver failure ( 32 ) and have been associated with further increased risk of bleeding ( 33 ) and thrombosis ( 34 ) in patients with liver disease. For example, a retrospective chart review study ( 33 ) analyzing patients with decompensated cirrhosis undergoing paracentesis (considered a low bleeding risk procedure by the 2019 Society of Interventional Radiology guidelines [ 21 ] similar to central vein cannulation), demonstrated that acute kidney injury before paracentesis was an independent predictor of post-paracentesis bleeding (odds ratio, 4.3; 95% CI, 1.3–13.5; p = 0.01), independent of coagulation parameters (platelets, INR), and severity of liver disease (MELD).…”
Section: Discussionmentioning
confidence: 99%